Center for Substance Abuse Prevention; Notice of Meeting, 78838 [2016-27032]

Download as PDF 78838 Federal Register / Vol. 81, No. 217 / Wednesday, November 9, 2016 / Notices Place: National Institutes of Health, Natcher Building, Rm 3AN12, 45 Center Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Lisa Dunbar, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3AN12, Bethesda, MD 20892, 301–594–2849, dunbarl@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: November 3, 2016. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–26971 Filed 11–8–16; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting sradovich on DSK3GMQ082PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Structural Birth Defects. Date: December 9, 2016. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Cathy J. Wedeen, Ph.D., Scientific Review Officer, Division of Scientific Review, OD, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS 6710B 16:29 Nov 08, 2016 Jkt 241001 Dated: November 3, 2016. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. Email: brian.makela@samhsa.hhs.gov. Brian Makela, Chemist, Substance Abuse and Mental Health Services Administration. [FR Doc. 2016–27032 Filed 11–8–16; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF THE INTERIOR Fish and Wildlife Service [FWS–R4–ES–2016–N193]; [FXES11140400000–178–FF04E00000] [FR Doc. 2016–26969 Filed 11–8–16; 8:45 am] Endangered Species Recovery Permit Applications BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention; Notice of Meeting BILLING CODE 4140–01–P VerDate Sep<11>2014 Bethesda Drive, Bethesda, MD 20892, 301– 435–6878, wedeenc@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory Board (DTAB) will meet via web conference on December 7, 2016, from 10:00 a.m. to 5:00 p.m. EST. The Board will meet in closed session on December 7, 2016, from 10:00am to 5:00pm, to review and discuss draft Mandatory Guidelines for Federal Workplace Drug Testing Programs (Hair) proposals. Therefore, this meeting is closed to the public as determined by the Administrator, SAMHSA, in accordance with 5 U.S.C. 552b(c)(9)(B) and 5 U.S.C. App. 2, Section 10(d). Meeting information and a roster of DTAB members may be obtained by accessing the SAMHSA Advisory Committees Web site, https:// www.samhsa.gov/about-us/advisorycouncils/drug-testing-advisory-boarddtab, or by contacting Brian Makela. Committee Name: Substance Abuse and Mental Health Services Administration’s Center for Substance Abuse Prevention, Drug Testing Advisory Board. Dates/Time/Type: December 7, 2016, from 10:00 a.m. to 5:00 p.m., EST: Closed. Place: Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857. Contact: Brian Makela, Division of Workplace Programs, 5600 Fishers Lane, Room 16N02B, Rockville, Maryland 20857. Telephone: 240–276–2600. Fax: 240–276–2610. PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 Fish and Wildlife Service, Interior. ACTION: Notice of receipt of permit applications; request for comment. AGENCY: We, the U.S. Fish and Wildlife Service, invite the public to comment on the following applications to conduct certain activities with endangered species. With some exceptions, the Endangered Species Act (Act) prohibits activities with listed species unless a Federal permit is issued that allows such activities. The Act requires that we invite public comment before issuing these permits. DATES: We must receive written data or comments on the applications at the address given in ADDRESSES by December 9, 2016. ADDRESSES: Reviewing Documents: Documents and other information submitted with the applications are available for review, subject to the requirements of the Privacy Act and Freedom of Information Act, by any party who submits a written request for a copy of such documents to the following office within 30 days of the date of publication of this notice: U.S. Fish and Wildlife Service Regional Office, Ecological Services, 1875 Century Boulevard, Atlanta, GA 30345 (Attn: Karen Marlowe, Permit Coordinator). Submitting Comments: If you wish to comment, you may submit comments by any one of the following methods: • U.S. mail or hand-delivery: Fish and Wildlife Service’s Regional Office (see above). • Email: permitsR4ES@fws.gov. Please include your name and return address in your email message. If you do not receive a confirmation from the Fish and Wildlife Service that we have received your email message, contact us directly at the telephone number listed in FOR FURTHER INFORMATION CONTACT. FOR FURTHER INFORMATION CONTACT: Karen Marlowe, Permit Coordinator, SUMMARY: E:\FR\FM\09NON1.SGM 09NON1

Agencies

[Federal Register Volume 81, Number 217 (Wednesday, November 9, 2016)]
[Notices]
[Page 78838]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-27032]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory 
Board (DTAB) will meet via web conference on December 7, 2016, from 
10:00 a.m. to 5:00 p.m. EST.
    The Board will meet in closed session on December 7, 2016, from 
10:00am to 5:00pm, to review and discuss draft Mandatory Guidelines for 
Federal Workplace Drug Testing Programs (Hair) proposals. Therefore, 
this meeting is closed to the public as determined by the 
Administrator, SAMHSA, in accordance with 5 U.S.C. 552b(c)(9)(B) and 5 
U.S.C. App. 2, Section 10(d).
    Meeting information and a roster of DTAB members may be obtained by 
accessing the SAMHSA Advisory Committees Web site, https://www.samhsa.gov/about-us/advisory-councils/drug-testing-advisory-board-dtab, or by contacting Brian Makela.

    Committee Name: Substance Abuse and Mental Health Services 
Administration's Center for Substance Abuse Prevention, Drug Testing 
Advisory Board.
    Dates/Time/Type: December 7, 2016, from 10:00 a.m. to 5:00 p.m., 
EST: Closed.
    Place: Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 
20857.
    Contact: Brian Makela, Division of Workplace Programs, 5600 
Fishers Lane, Room 16N02B, Rockville, Maryland 20857.
    Telephone: 240-276-2600.
    Fax: 240-276-2610.
    Email: brian.makela@samhsa.hhs.gov.

Brian Makela,
Chemist, Substance Abuse and Mental Health Services Administration.
[FR Doc. 2016-27032 Filed 11-8-16; 8:45 am]
 BILLING CODE 4162-20-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.